
HIGH RISK OF GESTATIONAL TROPHOBLASTIC
NEOPLASIA DEVELOPMENT IN RECURRENT
HYDATIDIFORM MOLES WITH NLRP7
PATHOGENIC VARIATIONS Kocabey M.1,a, Gulhan I.2, Koc A.1,b, Cankaya T.1, Karatasli V.2, Ileri A.3 *Corresponding Author: MD Mehmet Kocabey, Address: Güzelburc District Kıbrıs Street No: 81,
31175 Antioch/Hatay, e-mail: mehmet_kocabey@hotmail.com page: 45 download article in pdf format
|
Abstract
Objective: Pathogenic variations of the NLRP7 and
KHDC3L genes are responsible for familial recurrent hydatidiform
moles, a rare autosomal recessive phenomenon
that can lead to severe comorbidities. Little is known about
the diversity of genetic defects or the natural course of
disease progression among recurrent hydatidiform mole
cases from distinct ethnicities. In this study, we aimed to
investigate the mutation profile and pregnancy outcomes
in patients with multiple molar pregnancies.
Material and Methods: Three unrelated cases with
recurrent molar pregnancies are included in this study.
None of the patients had a known family history of molar
pregnancy. Clinical findings and follow-up results are
documented. Sanger sequencing is used to reveal genetic
defects in exons and exon-intron boundaries of NLRP7
and KHDC3L genes.
Results: NLRP7 pathogenic variants were found in all
three cases. In two cases, homozygous, c.2471+1G>A canonical
splice cite variant was identified and in one case a
homozygous, c.2571dupC (p.Ile858HisfsTer11) frameshift
variant was identified. No variant in the KHDC3L gene
was found in any case. In all cases, the development of
gestational trophoblastic neoplasia complicated the clinical
course and the treatment plans.
Conclusions: We found that defects of the NLRP7
gene are principally responsible for etiology in our region,
and the mutation profile suggests a founder effect in the
Turkish population. We suggest early genetic diagnosis
and counseling in molar pregnancies and recommend close
follow-up in terms of conversion to gestational trophoblastic
neoplasia.
|
|
|
|



 |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|